915 related articles for article (PubMed ID: 26157145)
1. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
2. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
3. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
[TBL] [Abstract][Full Text] [Related]
4. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
[TBL] [Abstract][Full Text] [Related]
5. Differential requirements of arrestin-3 and clathrin for ligand-dependent and -independent internalization of human G protein-coupled receptor 40.
Qian J; Wu C; Chen X; Li X; Ying G; Jin L; Ma Q; Li G; Shi Y; Zhang G; Zhou N
Cell Signal; 2014 Nov; 26(11):2412-23. PubMed ID: 25038452
[TBL] [Abstract][Full Text] [Related]
6. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
[TBL] [Abstract][Full Text] [Related]
7. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
8. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
9. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
[TBL] [Abstract][Full Text] [Related]
10. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.
Yabuki C; Komatsu H; Tsujihata Y; Maeda R; Ito R; Matsuda-Nagasumi K; Sakuma K; Miyawaki K; Kikuchi N; Takeuchi K; Habata Y; Mori M
PLoS One; 2013; 8(10):e76280. PubMed ID: 24130766
[TBL] [Abstract][Full Text] [Related]
11. GPR40-Mediated G
Rives ML; Rady B; Swanson N; Zhao S; Qi J; Arnoult E; Bakaj I; Mancini A; Breton B; Lee SP; Player MR; Pocai A
Mol Pharmacol; 2018 Jun; 93(6):581-591. PubMed ID: 29572336
[TBL] [Abstract][Full Text] [Related]
12. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
[TBL] [Abstract][Full Text] [Related]
13. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.
Szereszewski JM; Pampillo M; Ahow MR; Offermanns S; Bhattacharya M; Babwah AV
PLoS One; 2010 Sep; 5(9):e12964. PubMed ID: 20886089
[TBL] [Abstract][Full Text] [Related]
14. The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets.
Yashiro H; Tsujihata Y; Takeuchi K; Hazama M; Johnson PR; Rorsman P
J Pharmacol Exp Ther; 2012 Feb; 340(2):483-9. PubMed ID: 22106100
[TBL] [Abstract][Full Text] [Related]
15. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
16. The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1.
Bergeron V; Ghislain J; Poitout V
Islets; 2016 Nov; 8(6):157-164. PubMed ID: 27700527
[TBL] [Abstract][Full Text] [Related]
17. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
[TBL] [Abstract][Full Text] [Related]
18. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
Mancini AD; Poitout V
Trends Endocrinol Metab; 2013 Aug; 24(8):398-407. PubMed ID: 23631851
[TBL] [Abstract][Full Text] [Related]
19. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates
Senatorov IS; Cheshmehkani A; Burns RN; Singh K; Moniri NH
Mol Pharmacol; 2020 May; 97(5):304-313. PubMed ID: 32132133
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
